Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

A peptide from hair follicle stem cells promotes hair growth by activating specific skin cells.

Targeting NMMHC IIA may help treat blood-brain barrier damage.

Upadacitinib may cause hair loss.

The ALADIN score can predict how well patients with alopecia areata will respond to JAK inhibitor treatments.

Upadacitinib effectively treats psoriasiform eczema and some related conditions.

SIG-1451 could be a promising new treatment for atopic dermatitis.

Activated ras can protect kidney cells from a certain substance that causes cell death.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

Overexpressing noggin in mice causes severe osteoporosis.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

The osteopontin gene is active in a specific part of rat hair follicles during a certain hair growth phase and might affect hair cycle and diseases.

AMPK activation may reduce melanoma risk in red-haired individuals.

A variant in the ADAM17 gene causes hair loss by increasing protein degradation through TRIM47.

Truncated LTBP-1 disrupts TGF-β signaling, affecting hair growth.

PPARα agonists may help treat alopecia areata by reducing inflammation.

PRP can improve hair growth in people with hair loss, but more research is needed.

ADF8 and ADF11 help root hairs grow by responding to hormones and environmental signals.

NIPP1 is important for healthy skin and could help treat skin inflammation.

β1 integrin is essential for the survival, growth, and movement of human epithelial progenitor cells.

Senescent melanocytes can boost hair growth by activating hair stem cells.

ASC-CM is more effective than EV for treating osteoarthritis.

AP-1 and TGFß work together to drive resistance in basal cell carcinoma, suggesting new treatment options.

The chitosan-peptide system helps cartilage regeneration using fat-derived cells.

Adipose tissue therapies have advanced from tissue to cell and cell-free treatments, showing promise but also limitations.